Monday, June 15, 2026

TEMPEST Takes the Crown: Double Win at 2024 Brand Awards

The K-pop boy band TEMPEST won two awards at the 2024 Brand of the Year Awards.

Against Long Odds, a Jindo Dog Survives Rare Fungal Infection and Acute Kidney Injury

Taengi, a Jindo dog, battles systemic fungal infection and acute kidney injury, showing remarkable recovery through dedicated treatment.

Texas Dolce Project Marks New Step in Korea Southern Power’s North American Energy Storage Strategy

Korea Southern Power signed a joint development agreement for the Dolce BESS project in Texas with HD Hyundai Electric and others.

Tag: Dupixent

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.